Alk-Abelló A/S
🇩🇰Denmark
Efficacy of SLITone in House Dust Mite Allergic Patients
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 124
- Registration Number
- NCT00633919
- Locations
- 🇪🇸
Fernando Rodríguez, Santander, Cantabria, Spain
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 439
- Registration Number
- NCT00562159
Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)
Phase 3
Completed
- Conditions
- Interventions
- Biological: SCH 697243Drug: PlaceboDrug: Loratadine Syrup 1 mg/mL Rescue TreatmentDrug: Loratadine 10 mg Rescue TreatmentDrug: Olopatadine 0.1% Rescue TreatmentDrug: Mometasone furoate 50 mcg Rescue TreatmentDrug: Albuterol 108 mcg Rescue TreatmentDrug: Fluticasone 44 mcg Rescue TreatmentDrug: Prednisone 5 mg Rescue Treatment
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 345
- Registration Number
- NCT00550550
Tolerability of ALK Tree Tablet
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2008-02-29
- Lead Sponsor
- ALK-Abelló A/S
- Registration Number
- NCT00535639
- Locations
- 🇩🇰
PhaseOne Trials, Hvidovre, Denmark
Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2008-10-16
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 45
- Registration Number
- NCT00492076
- Locations
- 🇪🇸
Hospital Virgen del Camino, Allergology Service, Pamplona, Navarra, Spain
A Trial of Grazax in Subjects With Hayfever
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 329
- Registration Number
- NCT00421655
- Locations
- 🇺🇸
CompleWare Corporation, Iowa City, Iowa, United States
Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2008-03-06
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 76
- Registration Number
- NCT00413556
- Locations
- 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain
Efficacy and Safety of Grazax in Children
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2009-03-09
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 253
- Registration Number
- NCT00408616
- Locations
- 🇩🇪
Tangstedter Landstrasse 77, Hamburg, Germany
Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-10-18
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 800
- Registration Number
- NCT00389363
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Safety of ALK Ragweed Tablet
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2007-09-21
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 72
- Registration Number
- NCT00330083
- Locations
- 🇺🇸
Healthcare Discoveries Inc., San Antonio, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath